Received Feb 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Inflammation detected on mammogram; back ache; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. A female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for covid-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for covid-19 immunization; Covid-19 vaccine (DOSE 3, MANUFACTURER UNKNOWN), for covid-19 immunization. The following information was reported: INFLAMMATION (non-serious), outcome "recovered", described as "Inflammation detected on mammogram"; BACK PAIN (non-serious), outcome "recovered", described as "back ache". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of inflammation, back pain. Additional information: The patient did not receive any other vaccines on the same date as the vaccine for which you are reporting; unknown if patient receive any other vaccines within 4 weeks prior to the vaccine for which you are reporting and unknown if patient taking any other medications within 2 weeks of the event starting. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Test Name: mammogram; Result Unstructured Data: Test Result:inflammation